The present study showed that treatment with 20 mg/kg/day α-mangostin resulted in prolonged survival rates and increased inhibition of tumor growth and lymph node metastasis in an immunocompetent mouse metastatic mammary carcinoma model containing a p53 mutation. This evidence concerns the gene TP53 and neoplasm.